Professional Documents
Culture Documents
Chapter 2. Macroeconomics, Globalization and Health: Pre-Test
Chapter 2. Macroeconomics, Globalization and Health: Pre-Test
Pre-test
Page 1 of 7
Health Economics Chapter 2. Macroeconomics, globalization and health
Learning Objectives:
After the completion of the chapter, the students will be able to:
1. Explain key macroeconomic terms;
2. Identify links between macroeconomic activity, health and health care;
3. Describe the relationship between health care expenditure and GDP, population and health;
and
4. Describe the impact of globalization to health and health care through international trade.
What is Macroeconomics?
Macroeconomics deals with the performance and functioning of the economy as a whole
the relationships between economic growth, output, employment and inflation.
Economic growth is a positive change in the level of production of goods and services by
a country over a certain period of time. There are two indicators to measure the size of output of
the economy: GDP (Gross Domestic Product) and GNI (Gross National Income).
GDP is the main indicator and measure the total values of goods and services produced
within one year in a country. On the other hand, GNI, formerly called ‘gross national product’, is
concerned with measuring the output of economic activities undertaken by citizens and firms of
that country, regardless of where that activity takes place. Per capita GNI is used by the World
Bank to classify countries into stages of development. Table 2.1 shows the classification of
countries based on annual GNI data in 2019.
According to Umar Serajuddin and Nada Hamadeh of World Bank, there are two reasons
for changes of classifications:
1. In each country, factors such as economic growth, inflation, exchange rates, and
population growth influence GNI per capita. Revisions to national accounts methods and
data can also influence GNI per capita.
2. To keep the income classification thresholds fixed in real terms, they are adjusted annually
for inflation. The Special Drawing Rights (SDR) deflator is used which is a weighted
average of the GDP deflators of China, Japan, the United Kingdom, the United States,
and the Euro Area. This 2020, the thresholds have moved up in line with this inflation
measure.
Page 2 of 7
Health Economics Chapter 2. Macroeconomics, globalization and health
Activity 2.1
Compare and examine the Per Capita GNI of the ASEAN Nations on 2018 and 2020.
Classify them according to their income. Follow the table below.
Group 2018 2020
Low Income
Lower-middle income
Upper-middle income
High Income
Inflation is another macroeconomic term which refers to the general rise in prices through
time which results in a decrease in the value of money. For example, if prices increase by 7
percent this year, the goods or services that you can buy last year for P100, will cost P107 for
this year. A peso today is worth less than a peso last year in terms of purchasing power.
Inflation therefore is being measured using a price index.
producing those other goods. Thus, through specialization, free trade increases global
production, which increases product variety and reduces the cost of goods generally such that
overall wealth is increased. Those countries that engage in trade will therefore see increasing
GDP, a wider selection of available goods and services, higher employment and higher
government revenues (due to higher income). The problem of course is that, in practice, many
countries create barriers to trade to ‘protect’ domestic industries – barriers such as tariffs, import
restrictions and bans. The effect of such protection is that it enables countries to continue to
produce goods in which they have no comparative advantage, but at the same time discourages
those countries who do actually hold the comparative advantage in such products. Why would a
country do this? Usually it is to protect a specific interest group (e.g. a farm lobby, unions,
industry groups, etc.).
Figure 2.1 shows the linkages between the national and international macro level on
health.
Figure 2.1 Elements and linkages between health and national and international macro level
Source: Smith (2006)
The lower half of the figure represents the individual country under consideration, and the
upper half shows the aspects of the international system, which has expanded considerably in
influence in recent decades through globalization. The arrows between the various components
indicate the major linkages.
‘Health’ is highlighted as the major element at the bottom of the figure. A range of
influences are seen to impact upon health (including the health sector of course). Taking the
lower half of the figure first, what we may term as the ‘standard’ influences on health are
illustrated.
Page 4 of 7
Health Economics Chapter 2. Macroeconomics, globalization and health
In the upper half of the figure, shows other influencers outside the national economy. For
example, there are a wide variety of international influences directly upon risk factors for health,
including: an increased exposure to infectious disease through cross-border transmission of
communicable diseases; marketing of unhealthy products and behaviours; and environmental
degradation, the effects of which are often not contained within country borders. Increased
interaction in the global economic system will also affect health through influences upon the
national economy and wealth (Sachs 2001; Blouin et al. 2009). It is well established for instance
that economic prosperity is generally positively associated with increased life expectancy,
although increased wealth often brings with it an increase in many chronic illnesses. Finally,
health care will be affected through the direct provision and distribution of health-related goods,
services and people, such as access to pharmaceutical products, health-related knowledge and
technology (e.g. new genomic developments) and the movement of patients and professionals
(Smith et al. 2009). Also note that in the upper half of the figure we see the importance of
international legal and political frameworks that underpin much of these activities, such as
bilateral, regional and multilateral trade agreements.
In terms of linkages between these influences, the black arrows indicate those between
elements at the global or national level, and the striped arrows indicate specific forms of linkages
between the global and the domestic circumstance. The first striped arrow shows how increased
macroeconomic trade will bring associated changes in risk factors for disease. These will include
both communicable diseases, as trade encourages people and goods to cross borders; and non
communicable diseases, as changes in the patterns of food consumption, for example, are
influenced by changes in income and industry advertising. Second, increased macro-level
interaction will impact upon the domestic economy through changes in income and the
distribution of that income, as well as influencing tax receipts. This will influence the household
economy and also the abilities of government to be engaged in public finance and/or provision
of health care. Finally, the third striped arrow indicates that there will be direct interactions in
terms of health
related goods and services, such as pharmaceuticals and associated technologies, health care
workers and patients.
The spread of Communicable Diseases takes two ways: (1) the overall environment in
which people live (concerned with pollution, sanitation, etc.) is determined – in large part- by their
income and wealth; and (2) the increase in international movement of people, animals and goods
associated with increased trade will affect the movement of disease, i.e. COVID 19.
Perhaps less obvious is the relationship between macroeconomic activity and non
communicable diseases. Although macroeconomic growth can be beneficial when it leads to an
expansion in the consumption of the goods that improve health, such as clean water, safe food
and education, it also facilitates the increased consumption of goods which may be harmful or
hazardous to health, which may be termed ‘bads’. Trade liberalization will reduce the price of
Page 5 of 7
Health Economics Chapter 2. Macroeconomics, globalization and health
imported ‘bads’, through reduced tariff and non-tariff barriers, and increase the marketing of
‘bads’, such as tobacco, alcohol and ‘fast food’. In the case of alcohol and tobacco, the
development of regional trade agreements (RTAs) has helped to significantly reduce barriers to
trade in these products, by breaking up the hitherto protected markets that contribute to
enhanced consumption (Onzivu 2002; OECD 2003).
You are responsible for procuring drugs in your country. The Department of Health has a major
effort to improve drug supplies and almost doubled the drug budget over the past five years.
However, the extra effort did not have any effect. Complete the table to find out why it did not
become effective.
2. Compare the difference in your purchasing power through deflator: Price Index (base
year) ÷ Price index (current year)
3. Calculate the ‘real’ purchasing value of your US Dollar drugs budget. [Current US$ x
deflator]
4. What happen to your budget through time? Did the DOH make right decision? Explain
2015 2016 2017 2018 2019 2020
Drugs Budget
5,452,156.00 6,542,587.20 7,851,104.64 9,421,325.5 11,305,590.68 13,566,708.82
7
Total Current
US$ 229,045,073.56 285,714,783.02
Deflator 1 0.89
Finally, the health sector is increasingly involved in the direct trade of health-related
goods and services. For instance, spending on pharmaceuticals represents a significant portion
of health expenditure in all countries. They are also the single most important health-related
product traded, comprising some 55 per cent of all health-related trade by value (the share of
the next most significant health-related goods traded, small devices and equipment, is 19 per
cent). The market is highly concentrated, with North America, Europe and Japan accounting for
around 75 per cent of sales (by value) (Smith et al. 2009).
Overall, HICs produce and export high value patented pharmaceuticals and LICs and
MICs import these products, although some produce and export low-value generic products. This
leads to many developing countries experiencing a trade deficit in modern medicines, which
often fuels an overall health sector deficit. Interestingly, however, even among most HICs there
are considerable trade deficits in pharmaceuticals, given their overall levels of consumption.
Trade in health services has also expanded greatly in the last decade due to the push by the
World Trade Organization (WTO) for trade in services more generally under the General
Agreements on Tariffs and Trade (GATTs).
Globalization has in part been made possible due to improvements in information and
communication technology (Yach 1998). These improvements have also contributed to the
remote provision of health services from one country to another, known as ‘e-health’. Examples
of services provided include diagnostics, radiology, laboratory testing, remote surgery and tele
consultation.
Another type of trade in health services arises from the consumption of health services
abroad. This is also known as ‘health tourism’ and entails people choosing to go to another
country to obtain health care treatment. This attracts approximately 4 million patients each year,
with the global market being estimated to be $US40– 60 billion (Datta and Krishnan 2003).
Page 7 of 7